TAS0728

· Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS0728, covering 2024-09-05 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities [Phase 1]